Check out market updates

Brickell starts pivotal Phase III trial of drug candidate in U.S.

BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) has kicked off its final clinical trial in the U.S. for its anti-underarm […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *